Atlas Trials

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Clinical trial NCT05053295 · UNKNOWN

Trial details

NCT number
NCT05053295
Sponsor
Gangnam Severance Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed or Advanced Gastric AdenocarcinomaGastro-esophageal Junction Cancer
Start date
2021-07-02
Primary completion
2023-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.